On August 25, 2026, three insiders at Revolution Medicines, Inc. (RVMD) sold a combined total of approximately $18.11 million in company shares. Mark A. Goldsmith sold shares valued at roughly $7.52 million and an additional $5.19 million, while General Counsel Jeff Cislini sold shares worth approximately $5.40 million.
These transactions occurred at prices ranging from $208.37 to $209.26 per share. While insider selling can be motivated by various factors such as tax planning or portfolio diversification, the aggregated nature of these sales by multiple executives may attract investor attention. This follows a series of smaller sales by these same insiders earlier in the week.